NONMEM Users Network Archive

Hosted by Cognigen

[NMusers] Roivant Sciences - Director, Clinical Pharmacokinetics/Pharmacometrics

From: Brendan Johnson <Brendan.johnson_at_roivant.com>
Date: Tue, 10 Oct 2017 14:04:19 +0000

Director, Clinical Pharmacokinetics/Pharmacometrics
Roivant Sciences, Inc. is looking for a Director level clinical pharmacokin=
eticist/pharmacometrician that would have clinical pharmacology responsibil=
ities across a broad and growing therapeutic portfolio.
Apply at www.roivant.com<http://www.roivant.com/> or directly at https://bo=
ards.greenhouse.io/roivantsciences/jobs/871622?gh_jid=871622#.WdzMQGiPKUk
Details below:
LOCATION: Durham, NC or New York City, NY

THE COMPANY

Roivant Sciences is a development-stage biopharmaceutical company focused o=
n realizing the full value of promising drug candidates and systematically =
reducing the time, cost and risk of delivering new drugs to market. Roivant=
 aims to develop under-resourced or deprioritized drug candidates across th=
erapeutic areas of significant medical need.

Roivant is rapidly expanding its pipeline and the number of subsidiaries (o=
r "Business Units") around therapeutic areas of interest. There are current=
ly six "Vant" subsidiaries in areas that include dermatology, dementia, rar=
e disease, and women's health (www.roivant.com).



THE ROLE

Roivant's employees are its most important assets. We believe strongly in t=
he importance of building balanced teams, combining those with experience i=
n the biopharmaceutical industry with "natural athletes" who come from othe=
r industries - such as finance, consulting and technology - in order to cha=
llenge the status quo and shape the future of both our business and the pha=
rmaceutical industry.

We are seeking exceptional talent for the role of Director, Clinical Pharma=
cokinetics. The individual will provide a strategic role in the Clinical Ph=
armacology department assessing and determining pharmacokinetic (PK) progra=
ms and analysis techniques for use in clinical and nonclinical studies. He/=
she will also have a significant role in developing new capabilities for th=
e Clinical Pharmacology department within Roivant. This individual will be =
responsible for clinical pharmacology and PK support across therapeutic are=
as and all phases of clinical development, including development and execut=
ion of clinical pharmacology plans. The employee will be an integral member=
 of the project team using exploratory data analyses techniques, modeling, =
and simulation to accelerate development and support dosing, study designs,=
 and development plans. The employee will perform PK analyses or provide s=
cientific oversight of PK analyses performed at CROs. There will be signifi=
cant writing and review of regulatory documents, protocols, and study repor=
ts. The employee will also assist in due diligence efforts for potential a=
cquisition of new products and/or technologies.



We are looking for a top quality individual with the following characterist=
ics:

  * Deeply motivated self-starter with an entrepreneurial spirit
  * Desire to work in a quickly changing, fast-paced environment
  * Unrelenting dedication to delivering results and a desire to shape th=
e strategic goals of the business
  * Ability to overcome ambiguity and challenge the status quo
  * Willing to roll up your sleeves to get the job done



Requirements for consideration include:

  * MD, PharmD, or PhD degree
  * Minimum 5 years experience in the pharmaceutical industry conducting =
and managing pharmacokinetic and pharmacodynamic analyses
  * Experience includes a clinical pharmacology leadership role on a drug=
 development project team
  * Proven track record of clinical pharmacology/pharmacokinetics support=
 for regulatory interactions
  * Experience and expertise with Population PK/PD Modeling and/or PBPK m=
odeling is preferred



If you are interested in this role or in other opportunities at Roivant Sci=
ences, please apply at www.roivant.com<http://www.roivant.com/>


Brendan M. Johnson, Ph.D.
Senior Director, Pharmacokinetics
Roivant Sciences, Inc.
324 Blackwell St, Suite 1220,
Durham, NC 27701
brendan.johnson_at_roivant.com<mailto:brendan.johnson_at_roivant.com>
office: +1 (919) 425-5710
mobile:+1 (919) 572-9559

[cid:image001.png_at_01D275BD.54B5B930]
www.roivant.com<http://www.roivant.com/>

This e-mail message (including all attachments) is for the sole use of the =
intended recipient(s) and may contain confidential and privileged informati=
on. If you are not the intended recipient, you must not review, use, disclo=
se, copy, distribute or keep this email, its attachments or the message(s) =
or information contained in it or attached to it. If you are not the intend=
ed recipient, please contact the sender as soon as possible by reply e-mail=
 and thereafter immediately delete this email and destroy all copies of the=
 original message and any attachments. We have taken precautions to minimiz=
e the risk of transmitting software viruses, but we advise you to carry out=
 your own virus checks on any attachment to this message. We cannot accept =
liability for any loss or damage caused by software viruses.






image001.png
(image/png attachment: image001.png)

Received on Tue Oct 10 2017 - 10:04:19 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com. Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.